News & Notes

  • OTT Start-up: Neuronetics Goes Public on the NASDAQ ... View More
  • OTT Start-up: Syntermed appreciates the announcement that their Emory Cardiac Toolbox is now available thru GE Healthcare Life Systems ... View More
  • OTT Start-up: NeurOp Initiates Phase 1 Clinical Trial of NMDA Receptor Inhibitor ... View More
  • OTT Start-up: Cambium Receives $5M Series A Investment (View More) and Receives FDA Approval for Phase I/II Trial (View More)
  • OTT Start-up: Incysus Receives FDA Approval for Phase I Trial ... View More

Featured Innovation

Testing for Antibiotic Resistance

David Weiss, PhD

Weiss focuses his research on a phenomenon called heteroresistance. Hidden in the crowd are a few individual cells, perhaps one in a million, that are resistant to an antibiotic. His modified test is sensitive enough to detect these one-in-a-million bacteria and improves the speed and administration of antibiotics.

View More

Radiation Machine photo

Recent Twitter Posts